ACCA SBR — Strategic Business Reporting Practice Exam 2
4 free questions · No sign-up required to browse
A complete 100-mark mock exam replicating the ACCA Strategic Business Reporting (SBR) syllabus. This variant focuses on diverse business landscapes including renewable energy multinationals, AI tech startups, agricultural biotechnology, and public utilities, testing advanced IFRS application, group consolidations, and ethical reporting.
Difficulty breakdown
Topics covered
Browse all topics →Sample questions
SECTION A
AeroVentures Group (AV) is a multinational entity operating in the renewable energy sector. AV prepares its consolidated financial statements in US Dollars ($) to 31 December 20X5.
On 1 January 20X4, AV acquired 60% of the equity shares of BreezeCo, a wind-farm operator located in a foreign country whose functional currency is the Krone (KR). At the date of acquisition, AV recognized goodwill and measured the non-controlling interest (NCI) at fair value.
On 1 July 20X5, AV acquired a further 20% of the equity shares of BreezeCo for a cash consideration of $45 million. At this date, the carrying amount of BreezeCo's net assets in the consolidated financial statements was $150 million, and the carrying amount of the NCI was $62 million.
Separately, on 1 October 20X5, AV entered into a joint arrangement, 'SolarGrid', with another entity to construct and operate a large-scale solar power plant. AV and the other entity each hold a 50% voting right. The arrangement is structured through a separate vehicle. The legal form of the vehicle separates the obligations and assets of the vehicle from the parties. However, the contractual terms stipulate that AV and the other party are obligated to purchase 100% of the power generated by SolarGrid in proportion to their shareholdings, and SolarGrid cannot sell power to third parties.
Required:
(a) Explain, with supporting calculations, how the acquisition of the further 20% interest in BreezeCo should be accounted for in the consolidated financial statements of AV for the year ended 31 December 20X5. (12 marks)
(b) Discuss the principles under IAS 21 'The Effects of Changes in Foreign Exchange Rates' for translating the results and financial position of BreezeCo from Krone (KR) into US Dollars ($), including the specific treatment of goodwill arising on acquisition. (10 marks)
(c) Advise the directors of AV on how to determine whether the 'SolarGrid' arrangement should be classified as a joint operation or a joint venture under IFRS 11 'Joint Arrangements', and how it should be accounted for based on the specific facts provided. (8 marks)
SECTION A
NeuroTech Solutions (NTS) is a fast-growing technology startup specializing in artificial intelligence. NTS is currently preparing its financial statements for the year ended 31 December 20X5, ahead of a planned Initial Public Offering (IPO) in mid-20X6.
During the year, NTS incurred $8 million in costs developing a new predictive AI algorithm. The project began in January 20X5, but technical feasibility and the ability to generate future economic benefits were only established on 1 November 20X5. Costs incurred from 1 November to 31 December 20X5 amounted to $1.5 million. The CFO has instructed the financial controller, who is an ACCA member, to capitalize the entire $8 million as an intangible asset, stating: 'We need our balance sheet to look as strong as possible for the IPO investors. Everyone knows this algorithm is our golden ticket.'
Additionally, NTS signed several three-year Software-as-a-Service (SaaS) contracts with clients in December 20X5, receiving $3 million upfront. The CFO has directed that this entire $3 million be recognized as revenue in the 20X5 financial statements to boost the current year's earnings.
Required:
(a) Discuss the correct accounting treatment for the AI algorithm development costs and the SaaS revenue contracts under IFRS Accounting Standards for the year ended 31 December 20X5. (12 marks)
(b) Discuss the ethical and professional implications for the financial controller regarding the CFO's instructions, and recommend the actions the financial controller should take in accordance with the ACCA Code of Ethics and Conduct. (8 marks)
SECTION B
AgriGenetics Co is a large-scale agricultural biotechnology company that cultivates genetically modified crops designed to be drought-resistant. The company is preparing its financial statements for the year ended 31 December 20X5.
AgriGenetics has extensive plantations of growing crops. The crops take approximately eight months to reach maturity. At 31 December 20X5, the crops are halfway through their growth cycle. The company has incurred significant costs in planting and maintaining these crops. Management argues that because the crops are not yet mature, they should be held at cost. However, an active market exists for the crops at various stages of growth.
During the year, AgriGenetics received a $5 million government grant conditional upon the company maintaining its farming operations in a specific rural, economically deprived region for the next five years. If the company leaves the region before the end of the five years, the grant must be repaid in full.
Furthermore, an institutional investor group has written to the Board of Directors expressing concern about the long-term impact of climate change on the company's business model. They have specifically asked how climate-related risks are reflected in the current financial statements, particularly regarding asset valuations.
Required:
(a) Advise the directors of AgriGenetics on the correct recognition and measurement of the growing crops and the government grant in the financial statements for the year ended 31 December 20X5. (12 marks)
(b) Explain to the institutional investor group how climate-related risks should be considered and potentially reflected in the financial statements of AgriGenetics, with specific reference to relevant IFRS Accounting Standards. (13 marks)
SECTION B
MetroWater Co is a public utility company providing water treatment and distribution services.
On 1 January 20X5, MetroWater sold its primary water treatment facility to an investment bank for $100 million. The carrying amount of the facility just prior to the sale was $75 million. Its fair value was $100 million. Immediately upon sale, MetroWater leased the facility back for a period of 15 years. The remaining useful life of the facility is 40 years. The lease payments are $8 million per annum, payable in arrears. The interest rate implicit in the lease is 5%. The present value of the annual lease payments is $83 million. The transaction satisfies the requirements of IFRS 15 'Revenue from Contracts with Customers' to be accounted for as a sale.
Separately, MetroWater has an extensive network of underground pipelines. Under environmental legislation, MetroWater has a legal obligation to decommission and safely remove these pipelines at the end of their useful lives. A decommissioning provision was established years ago. On 31 December 20X5, due to new, stricter environmental laws, the estimated future cash outflows required to decommission the pipelines increased significantly. Furthermore, the discount rate used to measure the provision has decreased due to changing market conditions.
Required:
(a) Explain and calculate how the sale and leaseback of the water treatment facility should be accounted for in the financial statements of MetroWater for the year ended 31 December 20X5. (12 marks)
(b) Discuss how the changes in the estimated cash flows and the discount rate relating to the decommissioning provision should be accounted for under IAS 37 'Provisions, Contingent Liabilities and Contingent Assets' and IFRIC 1. Furthermore, explain the deferred tax implications (under IAS 12) of recognizing a decommissioning provision and the related asset. (13 marks)
Ready to Practice the full exam?
All 4 questions with worked answers, mark schemes, and AI tutoring.
Expert